HopeStage
Back to all studies
CompletedNCT00001656

Clozapine or olanzapine for psychosis in young people

About this titleRead the official source — NCT00001656
Medication studyAges 7–18United StatesSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 7 years to 18 years.

Listed locations
BethesdaSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJune 1997
Recruitment status
Completed
Enrollment listed in the registry
25
Sponsor
National Institute of Mental Health (NIMH)
Sponsor type
Government agency
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 7 Years to 18 Years
Official registry ID
NCT00001656
Official title
Show the full official title

Childhood Onset Psychotic Disorders: Characterization and Treatment With Atypical Neuroleptics

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Mental Health (NIMH), a government agency.

Did this study involve medication?

Yes. The study involved medication, including Olanzapine and Clozapine.

Who was this study for?

Listed age limits: 7 years to 18 years.

Want to explore more studies?

Explore studies